Membership pricing 10% off Active members save on every drip and injection, every visit
10.1080/13543784.2019.1627325 Expert Opin
Proponents claim these patches can suppress appetite, slow gastric emptying, and improve insulin secretioneffects associated with legitimate GLP-1 receptor agonists
FDAs Pharmacy Compounding Advisory Committee (PCAC) review of seven peptides for potential inclusion on the 503A Bulks List is scheduled for July 2324, 2026
It is commonly used alongside other peptides like Ipamorelin , which also supports GH secretion, for synergistic effects
For now, any GLP-1 patch being sold is not a legitimate, tested, or safe pharmaceutical product